<code id='72E0E430A6'></code><style id='72E0E430A6'></style>
    • <acronym id='72E0E430A6'></acronym>
      <center id='72E0E430A6'><center id='72E0E430A6'><tfoot id='72E0E430A6'></tfoot></center><abbr id='72E0E430A6'><dir id='72E0E430A6'><tfoot id='72E0E430A6'></tfoot><noframes id='72E0E430A6'>

    • <optgroup id='72E0E430A6'><strike id='72E0E430A6'><sup id='72E0E430A6'></sup></strike><code id='72E0E430A6'></code></optgroup>
        1. <b id='72E0E430A6'><label id='72E0E430A6'><select id='72E0E430A6'><dt id='72E0E430A6'><span id='72E0E430A6'></span></dt></select></label></b><u id='72E0E430A6'></u>
          <i id='72E0E430A6'><strike id='72E0E430A6'><tt id='72E0E430A6'><pre id='72E0E430A6'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:692
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Readout LOUD podcast: ALS dilemma, first MASH drug, and more
          Readout LOUD podcast: ALS dilemma, first MASH drug, and more

          Whathappenswhenanapproveddrugdoesn’twork?Whydon’tpatientswantgenetherapy?AndisMASHstillabigdeal?Weco

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Illumina board agrees to spin off Grail, as divestment plans proceed

          GrailIlluminasaidMondayafternoonthatitsboardofdirectorshadapprovedaspin-offofitscancertestsubsidiary